Smoking determines the 10-year (2004–2014) prognosis in patients with Acute Coronary Syndrome: the GREECS observational study
More details
Hide details
Department of Nutrition and Dietetics, School of Health Science and Education, Harokopio University, Glyfada, Greece
Cardiology Clinic, General Hospital of Chalkida, Chalkida, Greece
Cardiology Clinic, General Hospital of Karditsa, Karditsa, Greece
Cardiology Clinic, General Hospital of Zakynthos Island, Zakynthos, Greece
Cardiology Clinic, General Hospital of Lamia, Lamia, Greece
Cardiology Clinic, General Hospital of Kalamata, Kalamata, Greece
First Cardiology Clinic, School of Medicine, University of Athens, Athens, Greece
Demosthenes B. Panagiotakos   

Department of Nutrition and Dietetics, School of Health Science and Education, Harokopio University, 46 Paleon Polemiston St. 166 74, Glyfada, Athens, Greece
Publish date: 2015-11-25
Tobacco Induced Diseases 2015;13(November):38
Smoking has long been positively associated with the development and progression of coronary heart disease. However, longitudinal cohort studies evaluating smoking habits among cardiac patients as well as the role of socio-demographic factors determining such behaviours are scarce and have been focused on primary care practice. Thus the aim of the present work was to examine the association of active smoking and behaviours and exposure to second-hand smoke, with the 10-year Acute Coronary Syndrome (ACS) prognosis, among cardiovascular patients.

From October 2003 to September 2004, a sample of six Greek hospitals was selected and almost allconsecutive 2172 ACS patients were enrolled. In 2013–14, the 10-year follow-up was performed in 1918 participants (11 % loss to follow-up). Smoking habits at the time of entry to the study, as well as during the follow-up period were studied using a standard questionnaire.

Patients who had >60 pack-years of smoking had 57.8 % higher ACS mortality and 24.6 % higher risk for any ACS event. Nested model, adjusted only for age and sex, revealed that for every 30 pack-years of smoking increase, the associated ACS risk increased by 13 % (95 % CI 1.03, 1.30, p = 0.001). When further adjusted analysis, including several potential confounders, was applied the tested relationship was still significant (95 %CI 1.03, 1.30, p = 0.09). Accordingly, the risk for fatal ACS events increased by 8 % for every 30 pack-years of smoking increase (95 % CI 1.03, 1.63, p = 0.06). Moreover, 52 % of the patients reported being exposed to secondhand smoke and when further adjustments were made, it was revealed that they had 33 % (95 % CI 1.12, 1.60, p = 0.01) higher risk of having recurrent ACS events.

Active smoking and second-hand smoke among cardiac patients still represent a substantial clinical burden. Thus, smoking cessation policies should be incorporated into the long-term therapeutic management.

Kannel WB, Dawber TR, Kagan A, Revotskie N, Stokes 3rd J. Factors of risk in the development of coronary heart disease--six year follow-up experience. The Framingham Study. Ann Intern Med. 1961;55:33–50.
Keys A, Menotti A, Aravanis C, Blackburn H, Djordevic BS, Buzina R, et al. The seven countries study: 2,289 deaths in 15 years. Prev Med. 1984;13(2):141–54.
Raupach T, Schafer K, Konstantinides S, Andreas S. Secondhand smoke as an acute threat for the cardiovascular system: a change in paradigm. Eur Heart J. 2006;27(4):386–92. doi:10.1093/eurheartj/ehi601.
Panagiotakos DB, Rallidis LS, Pitsavos C, Stefanadis C, Kremastinos D. Cigarette smoking and myocardial infarction in young men and women: a case-control study. Int J Cardiol. 2007;116(3):371–5. doi:10.1016/j.ijcard.2006.04.051.
Pyrgakis VN. Smoking and cardiovascular disease. Hellenic J Cardiol. 2009;50(3):231–4.
Berndt N, Bolman C, Mudde A, Verheugt F, de Vries H, Lechner L. Risk groups and predictors of short-term abstinence from smoking in patients with coronary heart disease. Heart Lung. 2012;41(4):332–43. doi:10.1016/j.hrtlng.2012.03.001.
Griffo R, Ambrosetti M, Tramarin R, Fattirolli F, Temporelli PL, Vestri AR, et al. Effective secondary prevention through cardiac rehabilitation after coronary revascularization and predictors of poor adherence to lifestyle modification and medication. Results of the ICAROS Survey. Int J Cardiol. 2013;167(4):1390–5. doi:10.1016/j.ijcard.2012.04.069.
Scholte op Reimer W, de Swart E, De Bacquer D, Pyorala K, Keil U, Heidrich J, et al. Smoking behaviour in European patients with established coronary heart disease. Eur Heart J. 2006;27(1):35–41. doi:10.1093/eurheartj/ehi497.
Denollet J, Pedersen SS. Anger, depression, and anxiety in cardiac patients: the complexity of individual differences in psychological risk. J Am Coll Cardiol. 2009;53(11):947–9. doi:10.1016/j.jacc.2008.12.006.
Wiggers LC, Oort FJ, Dijkstra A, de Haes JC, Legemate DA, Smets EM. Cognitive changes in cardiovascular patients following a tailored behavioral smoking cessation intervention. Prev Med. 2005;40(6):812–21. doi:10.1016/j.ypmed.2004.09.028.
Lett HS, Blumenthal JA, Babyak MA, Catellier DJ, Carney RM, Berkman LF, et al. Dimensions of social support and depression in patients at increased psychosocial risk recovering from myocardial infarction. Int J Behav Med. 2009;16(3):248–58. doi:10.1007/s12529-009-9040-x.
Pitsavos C, Panagiotakos DB, Chrysohoou C, Skoumas J, Tzioumis K, Stefanadis C, et al. Association between exposure to environmental tobacco smoke and the development of acute coronary syndromes: the CARDIO2000 case-control study. Tob Control. 2002;11(3):220–5.
Munteanu I, Mihaltan FD. Second-hand Smoking and CV Risk. Curr Treat Options Cardiovasc Med. 2014;16(12):348. doi:10.1007/s11936-014-0348-8.
Barnoya J, Glantz SA. Cardiovascular effects of secondhand smoke: nearly as large as smoking. Circulation. 2005;111(20):2684–98. doi:10.1161/CIRCULATIONAHA.104.492215.
Dunbar A, Gotsis W, Frishman W. Second-hand tobacco smoke and cardiovascular disease risk: an epidemiological review. Cardiol Rev. 2013;21(2):94–100. doi:10.1097/CRD.0b013e31827362e4.
Borland R, Yong HH, Cummings KM, Hyland A, Anderson S, Fong GT. Determinants and consequences of smoke-free homes: findings from the International Tobacco Control (ITC) Four Country Survey. Tob Control. 2006;15 Suppl 3:iii42–50. doi:10.1136/tc.2005.012492.
Pitsavos C, Panagiotakos DB, Antonoulas A, Zombolos S, Kogias Y, Mantas Y, et al. Epidemiology of acute coronary syndromes in a Mediterranean country; aims, design and baseline characteristics of the Greek study of acute coronary syndromes (GREECS). BMC Public Health. 2005;5:23. doi:10.1186/1471-2458-5-23.
Braunwald E. Heart Disease. 5th ed. London, UK: W.B. Saunders Company; 1997.
Myocardial infarction redefined--a consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction. Eur Heart J. 2000;21(18):1502-13. doi:10.1053/euhj.2000.2305.
State-specific secondhand smoke exposure and current cigarette smoking among adults - United States, 2008. MMWR Morb Mortal Wkly Rep. 2009;58(44):1232-5. Last accessed March 7, 2015.
Panagiotakos DB, Pitsavos C, Arvaniti F, Stefanadis C. Adherence to the Mediterranean food pattern predicts the prevalence of hypertension, hypercholesterolemia, diabetes and obesity, among healthy adults; the accuracy of the MedDietScore. Prev Med. 2007;44(4):335–40. doi:10.1016/j.ypmed.2006.12.009.
Pate RR, Pratt M, Blair SN, Haskell WL, Macera CA, Bouchard C, et al. Physical activity and public health. A recommendation from the Centers for Disease Control and Prevention and the American College of Sports Medicine. JAMA. 1995;273(5):402–7.
Ariizumi H, Schirle T. Are recessions really good for your health? Evidence from Canada. Soc Sci Med. 2012;74(8):1224–31. doi:10.1016/j.socscimed.2011.12.038.
Shaw BA, Agahi N, Krause N. Are changes in financial strain associated with changes in alcohol use and smoking among older adults? J Stud Alcohol Drugs. 2011;72(6):917–25.
Giskes K, Kunst AE, Benach J, Borrell C, Costa G, Dahl E et al. Trends in smoking behaviour between 1985 and 2000 in nine European countries by education. J Epidemiol Community Health. 2005;59(5):395-401. doi:59/5/395 [pii]10.1136/jech.2004.025684.
Go AS, Mozaffarian D, Roger VL, Benjamin EJ, Berry JD, Blaha MJ, et al. Heart disease and stroke statistics--2014 update: a report from the American Heart Association. Circulation. 2014;129:e28-e292.
Violaris AG, Thury A, Regar E, Melkert R, Serruys PW. Influence of a history of smoking on short term (six month) clinical and angiographic outcome after successful coronary angioplasty. Heart. 2000;84(3):299–306.
Pollock JS, Hollenbeck RD, Wang L, Janz DR, Rice TW, McPherson JA. A history of smoking is associated with improved survival in patients treated with mild therapeutic hypothermia following cardiac arrest. Resuscitation. 2014;85(1):99–103. doi:10.1016/j.resuscitation.2013.08.275.
Kirtane AJ, Kelly CR. Clearing the air on the “smoker’s paradox”. J Am Coll Cardiol. 2015;65(11):1116–8. doi:10.1016/j.jacc.2015.01.012.
Yang Q, Cogswell ME, Flanders WD, Hong Y, Zhang Z, Loustalot F, et al. Trends in cardiovascular health metrics and associations with all-cause and CVD mortality among US adults. JAMA. 2012;307(12):1273–83. doi:10.1001/jama.2012.339.
Critchley JA, Capewell S. Mortality risk reduction associated with smoking cessation in patients with coronary heart disease: a systematic review. JAMA. 2003;290(1):86–97. doi:10.1001/jama.290.1.86 290/1/86.
Thyrian JR, Panagiotakos DB, Polychronopoulos E, West R, Zatonski W, John U. The relationship between smokers’ motivation to quit and intensity of tobacco control at the population level: a comparison of five European countries. BMC Public Health. 2008;8:2. doi:10.1186/1471-2458-8-2.
Tang L, Patao C, Chuang J, Wong ND. Cardiovascular risk factor control and adherence to recommended lifestyle and medical therapies in persons with coronary heart disease (from the National Health and Nutrition Examination Survey 2007-2010). Am J Cardiol. 2013;112(8):1126–32. doi:10.1016/j.amjcard.2013.05.064.
Japuntich SJ, Eilers MA, Shenhav S, Park ER, Winickoff JP, Benowitz NL, et al. Secondhand tobacco smoke exposure among hospitalized nonsmokers with coronary heart disease. JAMA Intern Med. 2015;175(1):133–6. doi:10.1001/jamainternmed.2014.5476.
Lim SS, Vos T, Flaxman AD, Danaei G, Shibuya K, Adair-Rohani H, et al. A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012;380(9859):2224–60. doi:10.1016/S0140-6736(12)61766-8.
CDC Fact Sheet Tobacco-Related Mortality. 2014. Available at: Last assessed March 17, 2015.
Panagiotakos DB, Pitsavos C, Chrysohoou C, Skoumas J, Masoura C, Toutouzas P, et al. Effect of exposure to secondhand smoke on markers of inflammation: the ATTICA study. Am J Med. 2004;116(3):145–50.
Vardavas CI, Panagiotakos DB. The causal relationship between passive smoking and inflammation on the development of cardiovascular disease: a review of the evidence. Inflamm Allergy Drug Targets. 2009;8(5):328–33.
Verheugt FW. Passive smoking and the risk of coronary heart disease. Ned Tijdschr Geneeskd. 2004;148(14):645–7.
Shiue I. Effect of smoking ban at home on adult cardiovascular health: Scottish Health Survey, 2012. Int J Cardiol. 2014;176(1):268–9. doi:10.1016/j.ijcard.2014.06.097.
Winickoff JP, Friebely J, Tanski SE, Sherrod C, Matt GE, Hovell MF, et al. Beliefs about the health effects of “thirdhand” smoke and home smoking bans. Pediatrics. 2009;123(1):e74–9. doi:10.1542/peds.2008-2184.
Huttunen-Lenz M, Song F, Poland F. Are psychoeducational smoking cessation interventions for coronary heart disease patients effective? Meta-analysis of interventions. Br J Health Psychol. 2010;15:749–77.
Eisenberg MJ, Blum LM, Filion KB, Rinfret S, Pilote L, Paradis G, et al. The efficacy of smoking cessation therapies in cardiac patients: a meta-analysis of randomized controlled trials. Can J Cardiol. 2010;26:73–9.
Rigotti NA, Pipe AL, Benowitz NL, Arteaga C, Garza D, Tonstad S. Efficacy and safety of varenicline for smoking cessation in patients with cardiovascular disease: a randomized trial. Circulation. 2010;121:221–9.
Beyens MN, Guy C, Mounier G, Laporte S, Ollagnier M. Serious adverse reactions of bupropion for smoking cessation: analysis of the French Pharmacovigilance Database from 2001 to 2004. Drug Saf. 2008;31:1017–26.
Patrick DL, Cheadle A, Thompson DC, Diehr P, Koepsell T, Kinne S. The validity of self-reported smoking: a review and meta-analysis. Am J Public Health. 1994;84(7):1086–93.
Wong SL, Shields M, Leatherdale S, Malaison E, Hammond D. Assessment of validity of self-reported smoking status. Health Rep. 2012;23(1):47–53.
Association between smoking and the peripheral vestibular disorder: a retrospective cohort study
Masaoki Wada, Taro Takeshima, Yosikazu Nakamura, Shoichiro Nagasaka, Toyomi Kamesaki, Eiji Kajii, Kazuhiko Kotani
Scientific Reports
Relation between secondhand smoke exposure and cardiovascular risk factors in never smokers
Sehun Kim, Si-Hyuck Kang, Donghoon Han, Sun-Hwa Kim, Hee-Jun Kim, JIN-Joo Park, Youngjin Cho, Yeonyee E. Yoon, Kyung-Do Han, Il-Young Oh, Chang-Hwan Yoon, Jung-Won Suh, Hae-Young Lee, Young-Seok Cho, Tae-Jin Youn, Goo-Yeong Cho, In-Ho Chae, Dong-Ju Choi, Cheol-Ho Kim
Journal of Hypertension
Effect of Intensive Personalized “5As+5Rs” Intervention on Smoking Cessation in Hospitalized Acute Coronary Syndrome Patients Not Ready to Quit Immediately: A Randomized Controlled Trial
Jing-guang Luo, Ling Han, Li-wei Chen, Yun Gao, Xiao-jun Ding, Ying Li, Ye Ja, Ming Yang, Chang-sheng Ma
Nicotine & Tobacco Research
Tobacco smoking and electronic cigarette: two sides of the same coin?
Dimitris Tousoulis
Hellenic Journal of Cardiology
Risk factors' management to impact on acute coronary syndromes
Lina Badimon, Judit Cubedo
International Journal of Cardiology
Handbook of nutrition in heart health
A. Kanberg, S. Durfey, R. Matuk, S. Cao, P. George